BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15718307)

  • 21. [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].
    Xu D; Meng FY; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):357-9. PubMed ID: 12422902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
    Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
    Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.
    Otani A; Takagi H; Oh H; Koyama S; Matsumura M; Honda Y
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1912-20. PubMed ID: 10440243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
    Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
    Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
    Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
    Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis.
    Câmpean V; Karpe B; Haas C; Atalla A; Peters H; Rupprecht H; Liebner S; Acker T; Plate K; Amann K
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1174-84. PubMed ID: 18272601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of endothelial cell-associated molecules in AML cells.
    Watarai M; Miwa H; Shikami M; Sugamura K; Wakabayashi M; Satoh A; Tsuboi K; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leukemia; 2002 Jan; 16(1):112-9. PubMed ID: 11840270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
    Szarvas T
    Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiopoietins, growth factors, and vascular morphology in early arthritis.
    Fearon U; Griosios K; Fraser A; Reece R; Emery P; Jones PF; Veale DJ
    J Rheumatol; 2003 Feb; 30(2):260-8. PubMed ID: 12563678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
    Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
    Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
    Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
    Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
    Tesan T; Gustavsson H; Welén K; Damber JE
    BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
    Zhang JQ; Wang JK; Li YM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P; David S; Haubitz M; Hellpap J; Horn R; Bröcker V; Schiffer M; Haller H; Witte T
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical importance of angiogenesis and angiogenic factors in oncohematology].
    Grosicki S; Grosicka A; Hołowiecki J
    Wiad Lek; 2007; 60(1-2):39-46. PubMed ID: 17607967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
    Li Q; Xu B; Fu L; Hao XS
    J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.